Montelukast use while Breastfeeding

Drugs containing Montelukast: Singulair

Montelukast Levels and Effects while Breastfeeding

Summary of Use during Lactation

No published information is available on the use of montelukast during breastfeeding. If montelukast is required by the mother, it is not a reason to discontinue breastfeeding. Because there is no published experience with montelukast during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Montelukast is approved for use in children as young as 6 months of age.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Beclomethasone, Cromolyn, Terbutaline, Theophylline, Zafirlukast

References

Montelukast Identification

Substance Name

Montelukast

CAS Registry Number

158966-92-8

Drug Class

Anti-Asthmatic Agents

Leukotriene Antagonists

Administrative Information

LactMed Record Number

600

Last Revision Date

20130907

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.

Hide
(web5)